Moog Considers Strategic Alternatives for Medical Device Business

After selling off its Ethox Medical division to Dempsey Ventures, a private equity firm specializing in medical products, Moog (NYSE: MOG-A  ) (NYSE: MOG-B  ) said Monday that it has retained an advisor to help it explore strategic alternatives for its entire medical device business, including its possible divestment.

While financial terms for the division's sale were not disclosed, Moog said Ethox's 88 employees generated approximately $12 million annually. It will incur an after-tax non-cash loss of approximately $5 million, or about $0.11 per share, as a result of the sale that will be reflected in its third-quarter financial reports.

Moog is a designer, manufacturer, and integrator of precision control components and systems, and said it hired RBC Capital Markets to assist with the strategic assessment of the remainder of its medical devices segment, which includes infusion therapy, post-operative pain management, enteral nutrition, and hospital products.

It had revenues of almost $2.5 billion in 2012. Shares of Moog closed the day yesterday up 3% at $53.05 and are at $52.70 as of this writing.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2521040, ~/Articles/ArticleHandler.aspx, 7/31/2014 10:46:01 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement